| HOME >> MEDICINE >> TECHNOLOGY |
952.426.6140 EVC Group
Jenifer Kirtland (Investors)
415.568.4887
Chris Gale (Media)
646.201.5431
UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)Three Months EndedNine Months EndedDecember 31December 312012201120122011Net sales
$5,590,431$5,344,188$16,877,394$14,964,932Cost of goods sold
734,171776,5382,264,7212,245,440Gross profit
4,856,2604,567,65014,612,67312,719,492Operating expenses General and administrative
1,058,558924,5243,178,2392,888,939 Research and development
533,867586,4391,695,8411,499,070 Selling and marketing
3,725,5303,902,95211,424,40711,366,969 Amortization
215,681215,164646,971641,5355,533,6365,629,07916,945,45816,396,513Operating loss
(677,376)(1,061,429)(2,332,785)(3,677,021)Other income (expense) Interest income
12,32714,26835,83645,818 Interest expense
(12)-(12)(57) Foreign currency exchange gain (loss)
445(11,025)(3,432)(14,304)12,7603,24332,39231,457Loss before income taxes
(664,616)(1,058,186)(2,300,393)(3,645,564)Income tax expense
12,7089,35235,81231,768Net loss
$(677,324)$(1,067,538)$(2,336,205)$(3,677,332)Basic and diluted loss per common share
$(0.03)$(0.05)$(0.11)$(0.18)Weighted average common shares outstanding:Basic and diluted
20,798,99720,718,34720,768,63220,678,865
UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)December 31, 2012March 31, 2012AssetsCurrent assets:Cash and cash equivalents & short-term investments
$14,423,486$11,854,127Accounts receivable, net
2,463,5722,704,434Inventories
835,153698,742Other
433,790363,639Total current assets
18,156,00115,620,942Property, plant, and equipment, net
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2012 PR Newswire. All rights reserved |